Monomeric Galectin-1 Purification Tag for Aggregation Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Recombinant protein purification using existing lectin-based methods is hindered by self-assembly and aggregation issues with human Galectin-1, leading to contamination and reduced purity, especially due to its dimerization property, which complicates the production and purification process.

Innovation Solution

Engineering variants of Cricetulus griseus galectin-1 with specific mutations at the dimerization interface to create monomeric, stable, and non-aggregating forms that retain lectin activity, allowing for high-specificity and high-yield purification using lactose-grafted Sepharose resin, and incorporating a TEV protease cleavage site for fusion proteins.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If human Galectin-1 is used as a purification tag, then lectin activity and binding specificity are achieved, but self-assembly and dimerization occur leading to aggregation and reduced purification purity

Engineering Contradiction:
Improvelectin activityVSAvoidaggregation
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The galectin-1 protein is segmented into two separate functional components: a monomeric galectin-1 variant that provides lectin activity and binding specificity, and a purification tag system using lactose-grafted Sepharose resin. The monomeric variant is engineered with mutations at the dimerization interface to prevent self-assembly while retaining carbohydrate recognition capability.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The amino acid sequence parameters of galectin-1 are modified through site-directed mutagenesis at the dimerization interface (specifically mutating cysteine and glutamate residues). These parameter changes alter the protein's oligomerization state from dimeric to monomeric while preserving the carbohydrate recognition domain's binding properties.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If lectin-based purification methods are used, then specific binding to polysaccharides is achieved, but non-specific binding to ungrafted resin occurs leading to contamination

Engineering Contradiction:
Improvebinding specificityVSAvoidnon-specific binding
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

Lactose molecules serve as intermediary binding mediators between the galectin-1 tag and the Sepharose resin. The lactose is covalently grafted to the resin, creating a specific ligand that binds only to the lectin domain of the fusion protein, thereby preventing non-specific interactions with the resin matrix itself.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention uses grafted Sepharose resin with controlled porosity and surface chemistry. The resin's porous structure is optimized to accommodate the lectin-lactose interaction while minimizing non-specific binding sites, and the grafting process modifies the resin surface to reduce hydrophobic and electrostatic non-specific interactions.

Inventive Principle:
Principle #31Porous materials

3Stability of the object's composition

If dimerization is allowed, then stability is improved, but purification complexity increases due to unwanted complexes

Engineering Contradiction:
ImprovestabilityVSAvoidpurification complexity
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The dimerization function is extracted and removed from the galectin-1 purification tag through targeted mutagenesis of the dimerization interface. This separation of functions allows the galectin-1 variant to retain only the essential lectin binding activity while eliminating the problematic self-assembly capability that complicates purification.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The engineered galectin-1 variants enable efficient and specific purification of proteins of interest as monomeric forms, reducing aggregation and improving yield, while maintaining lectin-like properties, facilitating single-step affinity chromatography and subsequent protein separation.

Implementation Method 1

The lectin capacities of galectins have been studied, in particular the properties of carbohydrate recognition domain (CRD) of human Galectin 3. This protein tag has the advantage of being highly specific for its ligand

Methodology Applied
Scientific EffectLectin-carbohydrate binding: Absorption (physical)

Implementation Method 2

Competition with an eluent molecule, or direct cleavage by a protease specifically recognising a target region embedded in the protein construct, releases the protein of interest from the beads

Methodology Applied
Scientific EffectProteolytic cleavage: Enzyme

Data Source

PatentEP4491629A1Expression system including an engineered lectin property purification tag based on galectin-1
Publication Date: 2025.01.15 UNIVERSITY OF LORRAINE
  • EP4491629A1 patent drawingFigure 1~2
  • EP4491629A1 patent drawingFigure 3
  • EP4491629A1 patent drawingFigure 4~5

AI summary

The present invention concerns a new expression system including an engineered lectin property purification tag derived from galectin-1, in particular Cricetulus griseus galectin-1 .